FT
IONS icon

Fiduciary Trust’s Ionis Pharmaceuticals IONS Stock Holding History

Fiduciary Trust’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$587K Hold
7,399
– – 0.01% 548
2026
Q1 		$556K Hold
7,399
– – 0.01% 551
2025
Q4 		$585K Buy
7,399
+1,022
+16% +$77K 0.01% 520
2025
Q3 		$417K Sell
6,377
-2,174
-25% -$106K ﹤0.01% 604
2025
Q2 		$338K Buy
8,551
+813
+11% +$26.6K ﹤0.01% 644
2025
Q1 		$233K Buy
+7,738
New +$253K ﹤0.01% 739
2020
Q3 		– Sell
-3,637
Closed -$214K – 554
2020
Q2 		$214K Buy
+3,637
New +$202K 0.01% 510
2020
Q1 		– Sell
-3,637
Closed -$220K – 515
2019
Q4 		$220K Sell
3,637
-20
-0.5% -$1.19K 0.01% 490
2019
Q3 		$219K Sell
3,657
-170
-4% -$11.1K 0.01% 489
2019
Q2 		$246K Sell
3,827
-350
-8% -$24.7K 0.01% 457
2019
Q1 		$339K Hold
4,177
– – 0.01% 392
2018
Q4 		$226K Sell
4,177
-106
-2% -$5.41K 0.01% 415
2018
Q3 		$220K Buy
+4,283
New +$201K 0.01% 446

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fiduciary Trust's IONS Position: Q2 2026 in Review

Fiduciary Trust held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 7,399 shares worth $587K. The position accounts for 0.01% of the portfolio, ranked #548.

Fiduciary Trust first reported a position in IONS in Q3 2018 and has held it in 13 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Fiduciary Trust held 7,399 shares of Ionis Pharmaceuticals worth $587K as of Q2 2026.
  • Fiduciary Trust left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
  • Ionis Pharmaceuticals made up 0.01% of Fiduciary Trust's portfolio in Q2 2026, its #548 holding.
  • Fiduciary Trust first reported a position in Ionis Pharmaceuticals in Q3 2018 and has held it in 13 quarters since.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.